These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10960771)

  • 21. Psoralen reverses the P-glycoprotein-mediated multidrug resistance in human breast cancer MCF-7/ADR cells.
    Jiang J; Wang X; Cheng K; Zhao W; Hua Y; Xu C; Yang Z
    Mol Med Rep; 2016 Jun; 13(6):4745-50. PubMed ID: 27082231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel anthracene derivative, MHY412, induces apoptosis in doxorubicin-resistant MCF-7/Adr human breast cancer cells through cell cycle arrest and downregulation of P-glycoprotein expression.
    De U; Chun P; Choi WS; Lee BM; Kim ND; Moon HR; Jung JH; Kim HS
    Int J Oncol; 2014 Jan; 44(1):167-76. PubMed ID: 24190517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PTRF/cavin-1 is essential for multidrug resistance in cancer cells.
    Yi JS; Mun DG; Lee H; Park JS; Lee JW; Lee JS; Kim SJ; Cho BR; Lee SW; Ko YG
    J Proteome Res; 2013 Feb; 12(2):605-14. PubMed ID: 23214712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Raf-1 and Bcl-2 induce distinct and common pathways that contribute to breast cancer drug resistance.
    Davis JM; Navolanic PM; Weinstein-Oppenheimer CR; Steelman LS; Hu W; Konopleva M; Blagosklonny MV; McCubrey JA
    Clin Cancer Res; 2003 Mar; 9(3):1161-70. PubMed ID: 12631622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The exogenous wild-type p14ARF gene induces growth arrest and promotes radiosensitivity in human lung cancer cell lines.
    Gao N; Hu YD; Cao XY; Zhou J; Cao SL
    J Cancer Res Clin Oncol; 2001; 127(6):359-67. PubMed ID: 11414196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular mechanisms of loss of beta 2-microglobulin expression in drug-resistant breast cancer sublines and its involvement in drug resistance.
    Ogretmen B; McCauley MD; Safa AR
    Biochemistry; 1998 Aug; 37(33):11679-91. PubMed ID: 9709006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of staurosporine and four analogues: their effects on growth, rhodamine 123 retention and binding to P-glycoprotein in multidrug-resistant MCF-7/Adr cells.
    Budworth J; Davies R; Malkhandi J; Gant TW; Ferry DR; Gescher A
    Br J Cancer; 1996 May; 73(9):1063-8. PubMed ID: 8624264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting P-glycoprotein and SORCIN: Dihydromyricetin strengthens anti-proliferative efficiency of adriamycin via MAPK/ERK and Ca
    Sun Y; Wang C; Meng Q; Liu Z; Huo X; Sun P; Sun H; Ma X; Peng J; Liu K
    J Cell Physiol; 2018 Apr; 233(4):3066-3079. PubMed ID: 28681913
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of competition of substrates for P-glycoprotein in MCF-7 breast cancer cells overexpressing MDR1.
    Hall JG; Cory AH; Cory JG
    Adv Enzyme Regul; 1999; 39():113-28. PubMed ID: 10470369
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gain-of-function p53 mutant with 21-bp deletion confers susceptibility to multidrug resistance in MCF-7 cells.
    Tsou SH; Hou MH; Hsu LC; Chen TM; Chen YH
    Int J Mol Med; 2016 Jan; 37(1):233-42. PubMed ID: 26572087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of multidrug resistance gene expression in human breast cancer cells by (-)-gossypol-enriched cottonseed oil.
    Ye W; Chang HL; Wang LS; Huang YW; Shu S; Dowd MK; Wan PJ; Sugimoto Y; Lin YC
    Anticancer Res; 2007; 27(1A):107-16. PubMed ID: 17352222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27
    Wang DD; Yang SJ; Chen X; Shen HY; Luo LJ; Zhang XH; Zhong SL; Zhao JH; Tang JH
    Tumour Biol; 2016 Nov; 37(11):15315-15324. PubMed ID: 27699665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Glutathione S-transferases in wild-type and doxorubicin-resistant MCF-7 human breast cancer cell lines.
    Wang K; Ramji S; Bhathena A; Lee C; Riddick DS
    Xenobiotica; 1999 Feb; 29(2):155-70. PubMed ID: 10199592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quercetin and doxorubicin co-encapsulated biotin receptor-targeting nanoparticles for minimizing drug resistance in breast cancer.
    Lv L; Liu C; Chen C; Yu X; Chen G; Shi Y; Qin F; Ou J; Qiu K; Li G
    Oncotarget; 2016 May; 7(22):32184-99. PubMed ID: 27058756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Down-regulation of c-fos by shRNA sensitizes adriamycin-resistant MCF-7/ADR cells to chemotherapeutic agents via P-glycoprotein inhibition and apoptosis augmentation.
    Shi R; Peng H; Yuan X; Zhang X; Zhang Y; Fan D; Liu X; Xiong D
    J Cell Biochem; 2013 Aug; 114(8):1890-900. PubMed ID: 23494858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Down-regulation of apoptosis-related bcl-2 but not bcl-xL or bax proteins in multidrug-resistant MCF-7/Adr human breast cancer cells.
    Ogretmen B; Safa AR
    Int J Cancer; 1996 Sep; 67(5):608-14. PubMed ID: 8782646
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin.
    Kim TH; Shin YJ; Won AJ; Lee BM; Choi WS; Jung JH; Chung HY; Kim HS
    Biochim Biophys Acta; 2014 Jan; 1840(1):615-25. PubMed ID: 24161697
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PA-MSHA inhibits the growth of doxorubicin-resistant MCF-7/ADR human breast cancer cells by downregulating Nrf2/p62.
    Wei Y; Liu D; Jin X; Gao P; Wang Q; Zhang J; Zhang N
    Cancer Med; 2016 Dec; 5(12):3520-3531. PubMed ID: 27758045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Annexin-I expression modulates drug resistance in tumor cells.
    Wang Y; Serfass L; Roy MO; Wong J; Bonneau AM; Georges E
    Biochem Biophys Res Commun; 2004 Feb; 314(2):565-70. PubMed ID: 14733945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Down-regulation of P-glycoprotein expression in MDR breast cancer cell MCF-7/ADR by honokiol.
    Xu D; Lu Q; Hu X
    Cancer Lett; 2006 Nov; 243(2):274-80. PubMed ID: 16406853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.